Therapeutic Asset Ratings
9,928 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Edotreotide
Central Nervous System Neoplasm
ITM Solucin GmbH
P1
CC
(43)
Edotreotide
Gastrointestinal Stromal Tumor
ITM Solucin GmbH
P1
CC
(43)
Edotreotide
Peripheral Primitive Neuroectodermal Tumor
ITM Solucin GmbH
P1
CC
(43)
Edoxaban
Morbid Obesity
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
P1
CC
(43)
Efineptakin Alfa
Urinary Bladder Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Efineptakin Alfa
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NeoImmuneTech
P1
CC
(43)
Eflornithine
Astrocytic Tumor
Orbus Therapeutics, Inc.
P1
CC
(43)
Egfr/B7H3 Car-T
Small Cell Lung Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Egfr/B7H3 Car-T
Neuroendocrine Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Egfrt/19-28Z/4-1Bbl Car T Cells
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Egfrt/19-28Z/Il-12 Car T-Lymphocytes
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Roswell Park Cancer Institute
P1
CC
(43)
Egfrt/19-28Z/Il-12 Car T-Lymphocytes
Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Egfrt/19-28Z/Il-12 Car T-Lymphocytes
B-Lymphoblastic Leukemia/Lymphoma With T(9;22)(Q34.1;Q11.2)
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Egfrt/19-28Z/Il-12 Car T-Lymphocytes
Follicular Lymphoma
Roswell Park Cancer Institute
P1
CC
(43)
Egfrt/19-28Z/Il-12 Car T-Lymphocytes
High Grade B-Cell Lymphoma
Roswell Park Cancer Institute
P1
CC
(43)
Egfrt/19-28Z/Il-12 Car T-Lymphocytes
Mantle Cell Lymphoma
Roswell Park Cancer Institute
P1
CC
(43)
Egfrt/19-28Z/Il-12 Car T-Lymphocytes
Diffuse Large B-Cell Lymphoma
Roswell Park Cancer Institute
P1
CC
(43)
Egfrt/19-28Z/Il-12 Car T-Lymphocytes
Adult Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Elebsiran
Liver Disorder
Vir Biotechnology, Inc.
P1
CC
(43)
Elenestinib
Systemic Mastocytosis
Blueprint Medicines Corporation
P1
CC
(43)
Elimusertib
Bile Duct Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Elimusertib
Breast Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Elimusertib
Cervical Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Elimusertib
Digestive System Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Elimusertib
Endometrial Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Showing 1901 to 1925 of 9,928 assets
Previous
Page 77 of 398
Next